clinical trial · NCT07119775

Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy

Congenital Myotonic DystrophyTideglusib

brief summary

This treatment plan is limited to a single patient with Congenital Myotonic Dystrophy, who is ineligible or otherwise unable to participate in ongoing clinical trials.

started

—

primary completion

—

completion

—

last updated

Aug 13, 2025

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol